CXCR4 as a novel predictive biomarker for metastasis and poor prognosis in colorectal cancer

Tumor Biology

Volumn 35, Issue 5, 2014, Pages 4171-4175

  Gao, Ying ^a   Li, Chunyu ^a   Nie, Min ^b   Lu, Yao ^a   Lin, Shunsen ^a   Yuan, Peng ^a   Sun, Xun ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b LIAONING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Colorectal cancer; CXCR4; Metastasis; Prognosis

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CXCR4; MESSENGER RNA; CXCR4 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; BONE METASTASIS; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; AGED; COLORECTAL TUMOR; LIVER TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STATISTICAL MODEL;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CXCR4; TUMOR MARKERS, BIOLOGICAL;

EID: 84902982175     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1545-x     Document Type: Article

References (17)

1. Broadbridge VT, Karapetis CS, Beeke C, Woodman RJ, Padbury R, Maddern G, et al. Do metastatic colorectal cancer patients who present with late relapse after curative surgery have a better survival? Br J Cancer. 2013;109(5):1338-43.
2. Reames BN, Krell RW, Ponto SN, Wong SL. Critical evaluation of oncology clinical practice guidelines. J Clin Oncol. 2013;31(20):2563-8.
3. Deo SV, Kapali AS, Gupta M, Shukla NK. A review of controversies in the management of colorectal cancers. Indian J Surg. 2012;74(3):221-7.
4. Hyder O, Dodson RM, Mayo SC, Schneider EB, Weiss MJ, Herman JM, et al. Post-treatment surveillance of patients with colorectal cancer with surgically treated liver metastases. Surgery. 2013;154(2):256-65.
5. Eichler K, Dufas T, Hammerstingl R, Gruber-Rouh T, Vogl TJ, Zangos S. Hepatic arterial infusion with irinotecan in patients with liver metastases of colorectal cancer: results of an extended phase I study. Chemotherapy. 2013;59(1):66-73.
6. Bullock MD, Bruce A, Sreekumar R, Curtis N, Cheung T, Reading I, et al. FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role. Br J Cancer. 2013;109(2):387-94.
7. Moriuchi M, Moriuchi H, Turner W, Fauci AS. Cloning and analysis of the promoter region of CXCR4, a coreceptor for HIV-1 entry. J Immunol. 1997;159(9):4322-9. (Pubitemid 127470589)
8. Caruz A, Samsom M, Alonso JM, Alcami J, Baleux F, Virelizier JL, et al. Genomic organization and promoter characterization of human CXCR4 gene. FEBS Lett. 1998;426(2):271-8. (Pubitemid 28198141)
9. He H, Wang C, Shen Z, Fang Y, Wang X, Chen W, et al. Upregulated expression of C-x-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer. PLoS One. 2013;8(8):e71864.
10. Qu QX, Huang Q, Xu J, Duan LT, Zhu YB, Zhang XG. CD40 signal regulates CXCR4 mediating ovarian carcinoma cell migration: implications for extrapelvic metastastic factors. Oncol Res. 2013;20(9):383-92.
11. Kremer KN, Peterson KL, Schneider PA, Meng XW, Dai H, Hess AD, et al. CXCR4 chemokine receptor signaling induces apoptosis in acute myeloid leukemia cells via regulation of the Bcl-2 family members Bcl-XL, Noxa, and Bak. J Biol Chem. 2013;288(32):22899-914.
12. Zhang HW, Sun XF, He YN, Li JT, Guo XH, Liu H. Bioinformatics analysis of breast cancer bonemetastasis related gene-CXCR4. Asian Pac J Trop Med. 2013;6(9):732-8.
13. Gillies K, Wertman J, Charette N, Dupré DJ. Anterograde trafficking of CXCR4 and CCR2 receptors in a prostate cancer cell line. Cell Physiol Biochem. 2013;32(1):74-85.
14. Strong VE, D'Amico TA, Kleinberg L, Ajani J. Impact of the 7th edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers. J Natl Compr Canc Netw. 2013;11(1):60-6.
15. Abou-Bakr AA, Elbasmi A. c-MET overexpression as a prognostic biomarker in colorectal adenocarcinoma. Gulf J Oncolog. 2013;1(14):28-34.
16. Luo DH, Chen QY, Liu H, Xu LH, Zhang HZ, Zhang L, et al. The independent, unfavorable prognostic factors endothelin A receptor and chemokine receptor 4 have a close relationship in promoting the motility of nasopharyngeal carcinoma cells via the activation of AKT and MAPK pathways. J Transl Med. 2013;11(1):203.
17. Segawa Y, Oda Y, Yamamoto H, Shiratsuchi H, Hirakawa N, Komune S, et al. Close correlation between CXCR4 and VEGF expression and their prognostic implications in nasopharyngeal carcinoma. Oncol Rep. 2009;21(5):1197-202.